mitomycin has been researched along with Fever in 12 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the therapeutic activity and safety of continuously infused mitomycin C in patients with metastatic colorectal cancer who had recurred (less than 3 months) or progressed following first- or second-line 5-fluorouracil-based chemotherapy." | 9.08 | Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer. ( Bokemeyer, C; Daikeler, T; Harstrick, A; Hartmann, JT; Kanz, L; Kollmannsberger, C; Müller, C; Seeber, S, 1998) |
| " Bleeding, infection, and fever were most common with adjuvant treatment (BCG or mitomycin)." | 5.12 | Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma. ( Linehan, J; Schoenberg, M; Seltzer, E; Smith, AB; Thacker, K, 2021) |
| "We evaluated the therapeutic activity and safety of continuously infused mitomycin C in patients with metastatic colorectal cancer who had recurred (less than 3 months) or progressed following first- or second-line 5-fluorouracil-based chemotherapy." | 5.08 | Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer. ( Bokemeyer, C; Daikeler, T; Harstrick, A; Hartmann, JT; Kanz, L; Kollmannsberger, C; Müller, C; Seeber, S, 1998) |
| "Hyperthermic mitomycin (HM) is a novel treatment modality for selected patients with high-risk non-muscle invasive bladder cancer (NMIBC)." | 3.83 | Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients. ( Ayres, BE; Bailey, M; Chiocchia, V; Dutton, S; Issa, R; Le Roux, P; Pai, A; Perry, MJ; Sooriakumaran, P; Swinn, M, 2016) |
| "Fourteen cases of adenocarcinoma with pleuritis carcinomatosa (lung cancer 10 cases, ovarian cancer 2 cases, colon cancer 2 cases) were treated with intra-pleural instillation of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083), a derivative of mitomycin C." | 3.67 | [Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa]. ( Eguchi, K; Garcia-Herreros, P; Hoshi, A; Nomori, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K, 1984) |
| "Thirty-six patients with hepatocellular carcinoma were treated by hepatic arterial chemoembolization of microencapslated mitomycin C (MMCmc)." | 3.67 | [Transcatheter hepatic arterial chemoembolization using microencapsulated mitomycin C (MMCmc)]. ( Fujii, M; Kamata, R; Sakabe, T; Takano, S; Tanaka, T; Yamaguchi, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Linehan, J | 1 |
| Schoenberg, M | 1 |
| Seltzer, E | 1 |
| Thacker, K | 1 |
| Smith, AB | 1 |
| Baron, E | 1 |
| Velez-Mejia, C | 1 |
| Sittig, M | 1 |
| Spiliotis, J | 1 |
| Nikiforchin, A | 1 |
| Lopez-Ramirez, F | 1 |
| Gushchin, V | 1 |
| Sardi, A | 1 |
| Sooriakumaran, P | 1 |
| Chiocchia, V | 1 |
| Dutton, S | 1 |
| Pai, A | 1 |
| Ayres, BE | 1 |
| Le Roux, P | 1 |
| Swinn, M | 1 |
| Bailey, M | 1 |
| Perry, MJ | 1 |
| Issa, R | 1 |
| ASHIGAWA, K | 1 |
| HATTORI, T | 1 |
| OKADA, K | 1 |
| Pérez, J | 1 |
| Rodríguez, MJ | 1 |
| Campaña, O | 1 |
| Veiras, S | 1 |
| Lorenzo, D | 1 |
| Lamas, M | 1 |
| Alvarez, J | 1 |
| Koga, S | 1 |
| Izumi, A | 1 |
| Maeta, M | 1 |
| Shimizu, N | 1 |
| Osaki, Y | 1 |
| Kanayama, H | 1 |
| Shimizu, E | 1 |
| Saijo, N | 1 |
| Shinkai, T | 1 |
| Eguchi, K | 1 |
| Tominaga, K | 1 |
| Nomori, H | 1 |
| Sasaki, Y | 1 |
| Garcia-Herreros, P | 1 |
| Hoshi, A | 1 |
| Sanz-Altamira, PM | 1 |
| Spence, LD | 1 |
| Huberman, MS | 1 |
| Posner, MR | 1 |
| Steele, G | 1 |
| Perry, LJ | 1 |
| Stuart, KE | 1 |
| Hartmann, JT | 1 |
| Harstrick, A | 1 |
| Daikeler, T | 1 |
| Kollmannsberger, C | 1 |
| Müller, C | 1 |
| Seeber, S | 1 |
| Kanz, L | 1 |
| Bokemeyer, C | 1 |
| Asanami, S | 1 |
| Shimono, K | 1 |
| Takano, S | 1 |
| Fujii, M | 1 |
| Tanaka, T | 1 |
| Sakabe, T | 1 |
| Yamaguchi, T | 1 |
| Kamata, R | 1 |
| Hattori, H | 1 |
| Mikuriya, S | 1 |
| Mamiya, T | 1 |
| Hatano, K | 1 |
| Shiina, T | 1 |
| Yamada, T | 1 |
1 review available for mitomycin and Fever
| Article | Year |
|---|---|
Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma.
Topics: BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Fever; Humans; Incidence; Kidney | 2021 |
2 trials available for mitomycin and Fever
| Article | Year |
|---|---|
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.
Topics: Abdominal Pain; Adult; Aged; Alkaline Phosphatase; Angiography; Antimetabolites, Antineoplastic; Ant | 1997 |
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer.
Topics: Adult; Aged; Anemia; Antibiotics, Antineoplastic; Colorectal Neoplasms; Diarrhea; Disease Progressio | 1998 |
9 other studies available for mitomycin and Fever
| Article | Year |
|---|---|
Delayed genital necrosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin-C.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Combined Modality Therapy; Cytoreduction Surgica | 2021 |
Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients.
Topics: Aged; Antibiotics, Antineoplastic; Biopsy; Carcinoma in Situ; Cohort Studies; Cystectomy; Cystoscopy | 2016 |
[EXPERIENCE WITH PULMONARY CANCER ACCOMPANIED BY CHRONIC FEVER].
Topics: Fever; Freund's Adjuvant; Geriatrics; Lung; Lung Abscess; Lung Neoplasms; Lymphatic Metastasis; Mito | 1963 |
[Anesthetic management for scheduled peritonectomy and hyperthermic intraperitoneal chemotherapy in 20 patients].
Topics: Adult; Aged; Analgesia, Epidural; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Intraveno | 2006 |
The effects of total-body hyperthermia combined with anticancer drugs on immunity in advanced cancer patients.
Topics: Adult; Antineoplastic Agents; Complement System Proteins; Cyclophosphamide; Doxorubicin; Female; Fev | 1983 |
[Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Colonic Neoplasms; Female; Fever; Huma | 1984 |
The effect of hyperthermia on micronucleus induction by mutagens in mice.
Topics: Alkylating Agents; Animals; Antimetabolites; Cell Nucleus; Colchicine; Cross-Linking Reagents; Cyclo | 1999 |
[Transcatheter hepatic arterial chemoembolization using microencapsulated mitomycin C (MMCmc)].
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Drug Compounding; Embolization, Therapeu | 1988 |
[Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; D | 1988 |